Annex 2 & Co. - GMP Compliance for Biopharmaceuticals - Live Online Training

27/28 May 2025, Vienna, Austria

Course No. 21817

header-image

Speakers

Dr. Marcus Fido

Dr. Marcus Fido

Mfi Bio-Consulting

Stephan Löw

Stephan Löw

CSL Behring

Dr. Matthias Leitritz

Dr. Matthias Leitritz

Rentschler Biopharma

Friederike Wedelich

Friederike Wedelich

Regierungspräsidium Tübingen

Dr. Marcel Günther

Dr. Marcel Günther

Regierungspräsidium Tübingen

Objectives

This Education Course concentrates on regulatory and practical requirements regarding biopharmaceutical production. From clinical phases to routine manufacturing, practical examples and case studies will facilitate the implementation of GMP in your daily Business.

The course will treat the topics of routine inspection from regulatory bodies and customers, quality assurance and quality control as well as in laboratory and production.

Speakers from manufacturing, laboratory, consultancy and authority will show their expectations as well as their experiences in GMP implementation.

Background

In defiance of all throwbacks in the last years, a progression of new approvals of biopharmaceuticals is expected.  Furthermore after the end of the protection of patents, biotechnical generics will be added.

Especially in the field of biotechnology you find often challenges to fulfil the regulatory requirements on production and quality assurance.

Industry and authorities have to face the new and expected changes in the regulatory Guidelines.

Target Group

This course is advisable to people who
  • are involved in regulatory inspections,
  • work in quality units at biotech companies,
  • implement GMP in biotech production,
  • are responsible for GMP requirements pre-approval phases.

Presentations / Certificate

The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site. After the event, you will automatically receive your certificate of participation.

Programme

Annex 2 & Co. - GMP Compliance for Biopharmaceuticals - Live Online Training

Seminar Programme as PDF

GMP Guidelines for Biopharmaceuticals – a Brief Summary
  • Relevant international regulations
  • European biotech guidance
  • Recent developments & possible impacts
GMP Requirements Applying to Biotechnological Investigational Medicinal Products (IMPs of Clinical Phases I-III & APIs for use in IMPs)
  • EU regulations & guidances
  • Examples of national regulations
  • State-of-the-art manufacturing for clinical phases
Development of Biopharmaceuticals – GMP, Regulatory Aspects and Inspection & Audit Experiences
  • EU and US guidances related to clinical trials GMP/CMC incl. Annex 13 update
  • CDMO considerations on specifications
  • Inspection and audit experiences “pre-approval”
Development, Qualification and Validation of Process Analytics for Biopharmaceuticals
  • Relevant guidelines
  • Phases of product development / testing requirements
  • Method portfolio/method development / method qualification / method validation
  • Product analytics & QC methods for product characterization
  • Relevant guidelines & publications
GMP Inspections in Biopharmaceutical Production
  • Inspections of biopharmaceutical companies
  • Focus & discussion points during inspections
    • Clean room classes for biotech facilities
    • Open vs. closed processing
    • Single- vs. multi-purpose equipment
    • Cell banking activities
  • Inspector’s experience, examples of observations
Process Transfer from Development to Commercial Production from a Quality Perspective
  • Definition and types of Transfers
  • Specific quality considerations for transfers
  • Transition from “development” to “Commercial”
GMP-conform Process Development and Validation (incl. Equipment Qualification)
  • Process development, manufacturing & dedicated instruments
  • Current initiatives in pharmaceutical development
  • Biopharmaceuticals / Biosimilars / Biologicals
  1. Process
  2. Analytical Methods
  3. Equipment / instruments and facility
Quality Assurance for Biopharmaceuticals
  • Classical responsibilities of QA department
  • Allocation of responsibilities, training of staff
  • Dealing with suppliers & contractors
  • The world changes: Change Management
  • Shit happens: Deviation Management & CAPA
  • Handling complaints & product  recalls
  • Paper, paper, paper: documentation works: SOPs, MBR, PQR & management report
  • Surveillance of qualification & validation, calibration and  maintenance
  • Self inspections & auditing
Bioanalytics for Clinical Trials – Method/Process Development and Validation for Phase I – III Studies
  • Definitions of terms (ICH guidelines, GCLP, GCP, GLP)
  • Process development & Quality by Design
  • Early clinical phases
  • Late clinical phases
  • Post-approval items & activities
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 1
  • Reasons for cell banking
  • Where does GMP start?
  • Characterization of cell banks
  • Storage of cell banks
State-of-the-art Biotechnological Manufacture (Bacteria, Yeast, Mammalian Cells) and Cell Banking Activities - Part 2
  • Overview of a typical biotech process
  • Requirements on production areas, raw materials and equipment
  • Specialities on biotech products
  • Fill and finish
mRNA Technology – Principles, Manufacturing and Regulatory Perspective
  • COVID vaccines: Viral and mRNA vaccines
  • Modular principle of mRNA-based vaccines and mRNA vaccine manufacturing
  • Regulatory perspective on mRNA products
  • Application process for updating the MIA
  • GMP challenges for new biological products
Annex 1 – Impact on the Manufacturing of Biopharmaceuticals
  • Annex 1: What is the Annex 1 and why is it revised?
  • Key principles of the revised Annex 1
  • Impact on facility, equipment, personal, raw materials, QRM, CCS, …
  • Case Study: Implementation in the daily business

stop

This course is part of the GMP Certification Programme "ECA Certified Biotech Manager" Learn more

ECA-Member*: € 1690,-
Non ECA Member*: € 1890,-
EU/GMP Inspectorates*: € 945,-
APIC Member Discount*: € 1790,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023